Company Filing History:
Years Active: 2005
Title: Günter Benz: Innovator in Pharmaceutical Chemistry
Introduction
Günter Benz is a notable inventor based in Velbert, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications.
Latest Patents
Günter Benz holds a patent for the use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases. This patent includes pharmaceutical compositions containing these compounds and outlines a process for their use. The compounds of the invention are characterized by a generalized formula that includes various aryl or heteroaryl rings and substituent groups, which are essential for their therapeutic efficacy.
Career Highlights
Günter Benz is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical company. His work focuses on innovative solutions for treating respiratory diseases, showcasing his commitment to advancing medical science.
Collaborations
He has collaborated with esteemed colleagues such as Mary F Fitzgerald and Philip J Gardiner, contributing to a dynamic research environment that fosters innovation.
Conclusion
Günter Benz's contributions to pharmaceutical chemistry and his innovative patent demonstrate his dedication to improving healthcare through scientific advancements. His work continues to influence the development of effective treatments for respiratory diseases.